Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM-TMAO: Compound Panax Notoginseng Granule in ACS
NCT03186625Unknown
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Dec 2017
- Primary completion
- May 2018
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Randomised, double-blind trial of compound panax notoginseng in acute coronary syndrome (ACS), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Trimethylamine N-oxide at 90 days. Status: unknown.
02
Drugs
compound panax notoginseng
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03186625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186625.